Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

Draft designation of pharmaceuticals under Article 80 of the Pharmaceuticals Act Enforcement Order

医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律施行令第八十条第二項第七号ヘの規定に基づき厚生労働大臣の指定する医薬品(案)に関する御意見の募集について

Published: 2026-11-10 · Source: e-Gov Public Comment · Stage: Public Comment Open · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · Comment deadline: 2026-12-09 23:59 JST · First detected by this dashboard: 2026-11-11

View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

The Ministry of Health, Labour and Welfare published a draft designation of pharmaceuticals for public comment on 2026-11-10. The proposed designation is by the Minister under Article 80, paragraph 2, item 7(f) of the Enforcement Order of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. The stated comment deadline is 2026-12-09 23:59 JST; the responsible office is the Compliance and Narcotics Division, Pharmaceutical Safety Bureau.

Business Impact

The proposal may concern pharmaceutical businesses handling the products proposed for designation. The supplied listing does not identify those products or explain the practical consequences of designation.

Recommended Action

A possible review is to check the draft's pharmaceutical list and the consequences of designation under Article 80, paragraph 2, item 7(f), including whether any products handled by the business are covered.